79312865 - BACHEM LEADING PARTNER IN TIDES

Information

  • Trademark
  • 79312865
  • Serial Number
    79312865
  • Filing Date
    November 06, 2020
    4 years ago
  • Transaction Date
    February 27, 2023
    a year ago
  • Status Date
    February 07, 2022
    2 years ago
  • Location Date
    February 07, 2022
    2 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    BERTRAND, JOSEPH A
  • Law Office Assigned Location Code
    M20
  • Owners
Mark Drawing Code
4000
Mark Identification
BACHEM LEADING PARTNER IN TIDES
Case File Statements
  • GS0401: Custom manufacturing; custom manufacture of pharmaceutical products; custom manufacture of biopharmaceutical products; custom manufacture of peptides; custom manufacture of proteins; custom manufacture of oligonucleotides; custom manufacture of small molecules; treatment of materials; treatment of chemical products; treatment of chemical reagents; treatment of peptides; treatment of proteins; treatment of oligonucleotides; treatment of small molecules; treatment of medicinal materials; treatment of biopharmaceutical materials for third parties; refining services; treatment of materials; treatment of biopharmaceutical materials; treatment of materials on request for third parties; treatment of materials for third parties
  • GS0051: Chemical reagents for medical or veterinary use; reagents for medical use; chemical preparations for medical use; peptides for medical use; proteins for medical use; oligonucleotides for medical use; small molecules for medical use; amino acids for medical use; chemical preparations for pharmaceutical use; peptides for pharmaceutical use; synthetic peptides for pharmaceutical use; proteins for pharmaceutical use; oligonucleotides for pharmaceutical use; small molecules for pharmaceutical use; chemical preparations for veterinary use; peptides for veterinary use; proteins for veterinary use; oligonucleotides for veterinary use; small molecules for veterinary use; amino acids for veterinary use; pharmaceutical preparations; pharmaceutical preparations containing amino acids; pharmaceutical substances; chemical-pharmaceutical preparations; diagnostic preparations for medical purposes; diagnostic preparations for veterinary use; biological and pharmaceutical preparations for diagnostic purposes; diagnostic test reagents for medical or veterinary use; peptides for diagnostic purposes; proteins for diagnostic purposes; oligonucleotides for diagnostic purposes; small molecules for diagnostic purposes; diagnostic kits containing diagnostic agents, preparations and substances for medical use; chemical preparations for the diagnosis of pregnancy; biochemical preparations for medical or veterinary use; biological and chemical reagents for medical or veterinary use; biological preparations for diagnostic purposes; biological preparations for medical use; biological preparations for veterinary use; preparations against metabolic diseases; preparations for wound healing; preparations against genetic diseases; preparations against neurological diseases; biological reagents for medical use; biological reagents for veterinary use; adjuvants for medical use; adjuvants for veterinary use; antibacterial preparations; anti-cancer preparations; anti-tumor medicines; biopharmaceutical products for cancer treatment; biotechnological preparations for medical use; anti-cancer preparations; anti-diabetic preparations; pharmaceutical preparations for use in chemotherapy; clinical diagnostic reagents; cosmeceuticals for therapeutic or medical use; dermatological preparations; diagnostic biomarker reagents for medical use; food supplements with cosmetic effect; dietetic substances adapted for medical use; dietetic substances adapted for veterinary use; drug delivery agents; injectable solutions for medical use; in-vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences for medical and veterinary use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing
  • GS0011: Chemicals intended for industry and science; chemical preparations for scientific use; chemical preparations for use in industry; industrial chemicals; reagents for research purposes; reagents for scientific use; reagents for chemical analyses; chemical preparations for scientific use, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary use; industrial chemicals; chemical reagents for scientific use; peptides for use in industry and science; proteins for use in industry and science; oligonucleotides for use in industry and science; small molecules for use in industry and science; oligopeptides for industrial use; proteins for industrial use; oligonucleotides for industrial use; proteins for use in manufacture; oligonucleotides for use in manufacture; amino acids for industrial purposes; amino acids for scientific use; peptide substrates for scientific use; chemical preparations for use in the manufacture of cosmetics; peptides for use in the manufacture of cosmetics; proteins for use in the manufacture of cosmetics; oligonucleotides for use in the manufacture of cosmetics; small molecules for use in manufacture of cosmetics; chemical preparations for use in the manufacture of medicines; chemical preparations for use in the manufacture of pharmaceuticals; peptides for use in the manufacture of pharmaceuticals; proteins for use in the manufacture of pharmaceuticals; oligonucleotides for use in the manufacture of pharmaceuticals; small molecules for use in manufacture of pharmaceutical products; chemical reagents for genetic research; chemical products for use in biotechnological manufacturing processes; chemical products used in the development of biotechnological products; active chemical ingredients for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of anti-cancer medicines; active chemical ingredients for use in the manufacture of medicines against diabetes; active chemical ingredients for use in the manufacture of medicines against metabolic diseases; active chemical ingredients for use in the manufacture of medicines for wound healing; active chemical ingredients for use in the manufacture of medicines against genetic diseases; active chemical ingredients for use in the manufacture of medicines against neurological diseases; amides for use in manufacture; chemical additives for use in manufacture; chemical additives for use in manufacture of cosmetics; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific or research use; diagnostic preparations, other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents, other than for medical or veterinary use; biological preparations for use in industry and science; biological preparations, other than for medical or veterinary use; additives, other than for medical or veterinary use; biochemical catalysts; biochemical precursors for scientific use; biochemical preparations for scientific use; oligonucleotides for scientific use; proteins for scientific use; peptides for scientific use; biochemical products for in-vitro and in-vivo scientific use; emollients for industrial use; emollients for use in the manufacture of cosmetics; emollients for use in the manufacture of pharmaceutical products; enzyme stabilizers; enzymatic substrates; phosphoproteins
  • GS0421: Scientific research; chemical research; chemistry services; chemical engineer; research and development of products; research and development of new products for third parties; industrial research, development and testing; research and development services in the field of chemistry; research and development in the field of peptides; research and development in the field of proteins; research and development in the field of oligonucleotides; research and development in the field of small molecules; research and development services for the pharmaceutical industry; research and development services in the field of pharmaceutical preparations; research and development services in the field of biochemistry; research and development services in the field of cosmetics; research and development services in the field of diagnostic preparations; research and development services in the field of gene expression systems; research in the fields of chemistry and biology; development of manufacturing processes; development of analytical methods; scientific laboratory services; chemical and biological laboratory services; scientific and industrial analysis and research services; laboratory research and analysis; chemical analysis; industrial analysis; laboratory analysis services; chemical, biochemical, biological and bacteriological research and analysis; analysis in the field of molecular biology; computer-assisted scientific research, testing and analysis services; conducting of scientific studies; preparation of reports concerning scientific research; provision of information on industrial analysis and research services; quality control; product testing; evaluation of chemical analyses; evaluation of chemical syntheses; evaluation of product development; consulting services relating to testing of materials; consultation in the field of biochemistry; consultation in the field of chemistry; consulting in the field of scientific and industrial research; consultation relating to laboratory testing; consulting services in the field of recombinant DNA technology
Case File Event Statements
  • 2/27/2023 - a year ago
    18 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT
  • 2/7/2023 - a year ago
    17 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/7/2023 - a year ago
    16 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/4/2022 - 2 years ago
    15 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 11/16/2022 - 2 years ago
    14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/16/2022 - 2 years ago
    13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 2/7/2022 - 2 years ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/7/2022 - 2 years ago
    11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/7/2022 - 2 years ago
    10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 8/15/2021 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/26/2021 - 3 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/26/2021 - 3 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/18/2021 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/17/2021 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/15/2021 - 3 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/11/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/11/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/10/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR